Literature DB >> 3556983

Intravenous cisapride accelerates delayed gastric emptying and increases antral contraction amplitude in patients with primary anorexia nervosa.

G Stacher, H Bergmann, S Wiesnagrotzki, A Kiss, C Schneider, G Mittelbach, G Gaupmann, J Höbart.   

Abstract

Delayed gastric emptying is common in primary anorexia nervosa. We investigated in 12 patients whether gastric emptying could be accelerated by the prokinetic drug cisapride. Patients were studied on two occasions 1 wk apart and received, under random double-blind conditions, 8 mg of cisapride and placebo intravenously. Gastric emptying of an isotopically labeled semisolid meal and antral motor activity were measured using a dual-headed gamma-camera for 50 min. Emptying was significantly slower (half-emptying time, 50-191 min; median, 121 min) than in 24 healthy volunteers (half-emptying times, 21-119 min; median, 47 min). Cisapride accelerated emptying significantly (p less than 0.001; half-emptying time after cisapride, 22-80 min; median, 42 min). Antral contraction amplitude increased and contraction frequency decreased significantly (p less than 0.001), whereas the propagation velocity of contractions remained unchanged. We concluded that intravenous cisapride accelerates gastric emptying and increases antral contraction amplitude in patients with anorexia nervosa. Whether or not these effects can prove beneficial in diminishing the patients' symptoms and in helping them to gain weight can only be answered from studies involving long-term treatment with cisapride.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3556983     DOI: 10.1016/0016-5085(87)90976-0

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  24 in total

1.  Slow gastric emptying induced by high fat content of meal accelerated by cisapride administered rectally.

Authors:  G Stacher; G V Granser; H Bergmann; A Kugi; G Stacher-Janotta; J Höbart
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

2.  Longterm oral cisapride improves interdigestive antroduodenal motility in dyspeptic patients.

Authors:  P A Testoni; F Bagnolo; L Fanti; S Passaretti; A Tittobello
Journal:  Gut       Date:  1990-03       Impact factor: 23.059

3.  Effects of the 5-HT3 receptor antagonist ICS 205-930 on fat-delayed gastric emptying and antral motor activity.

Authors:  G Stacher; H Bergmann; C Schneider; G Steiner-Mittelbach; G Gaupmann; H Steinringer; T A Abatzi; G Stacher-Janotta
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

Review 4.  Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders.

Authors:  R W McCallum; C Prakash; D M Campoli-Richards; K L Goa
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

Review 5.  Rational pharmacotherapy of gastrointestinal motility disorders.

Authors:  P Demol; H J Ruoff; T R Weihrauch
Journal:  Eur J Pediatr       Date:  1989-04       Impact factor: 3.183

6.  Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis--effects of cisapride.

Authors:  R J Fraser; M Horowitz; A F Maddox; J Dent
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

7.  Acid, motility, and ulcers: a comparison of cisapride with placebo in the prevention of duodenal ulcer relapse.

Authors:  D D Kerrigan; M E Taylor; N W Read; A G Johnson
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

8.  Normal gastric antral myoelectrical activity in early onset anorexia nervosa.

Authors:  A M Ravelli; B A Helps; S P Devane; B D Lask; P J Milla
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

9.  Lack of systematic effects of the 5-hydroxytryptamine 3 receptor antagonist ICS 205-930 on gastric emptying and antral motor activity in patients with primary anorexia nervosa.

Authors:  G Stacher; H Bergmann; G V Granser-Vacariu; S Wiesnagrotzki; T A Wenzelabatzi; G Gaupmann; A Kugi; H Steinringer; C Schneider; J Höbart
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

10.  Measurement of gastric emptying and gastric motility by magnetic resonance imaging (MRI).

Authors:  W Schwizer; R Fraser; J Borovicka; G Crelier; P Boesiger; M Fried
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.